FULC
Fulcrum Therapeutics Inc
3.70$
-0.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -132.4% | – | – | – | – | – | – | – | – | |
| – | -4.3% | -5.7% | -21.5% | -1.9% | +0.0% | -4.3% | -2.5% | +0.6% | +0.3% | -2.6% | -36.1% | – | |
| – | -7.7% | +13.5% | +10.9% | -12.1% | -35.1% | +27.9% | -9.2% | +16.9% | -8.8% | +25.9% | -15.3% | – | |
| – | – | – | – | – | – | – | – | +70.3% | -77.9% | -750.2% | – | – | |
| – | +18.5% | -63.6% | -100.0% | – | +1,115.8% | -100.0% | – | +38.5% | +76.7% | -95.0% | +1,250.0% | – | |
| – | -3.5% | +107.7% | -132.8% | – | -48.0% | -134.4% | – | +33.6% | -105.6% | +12,122.1% | – | – | |
| – | -99.8% | +475.3% | -77.2% | +68.4% | -86.9% | -100.0% | – | -78.7% | +262,871.9% | -100.2% | – | – | |
| – | – | – | +225.0% | -130.1% | – | – | – | +983.6% | +3,253.9% | -197.9% | – | – | |
| – | – | – | – | -132.4% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.